Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Interpace Biosciences Inc (ID) IDXG

Healthcare Medical Care Diagnostics & Research
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT... see more

Current News ()

Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners

GlobeNewswire December 3, 2025

Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results

GlobeNewswire November 12, 2025

Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting

GlobeNewswire September 15, 2025

Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results

GlobeNewswire August 7, 2025

Interpace Biosciences Announces First Quarter 2025 Financial and Business Results

GlobeNewswire May 8, 2025

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

GlobeNewswire April 24, 2025

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

GlobeNewswire January 31, 2025

PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan

GlobeNewswire January 27, 2025

Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

GlobeNewswire January 9, 2025
View More News ››

Opinion & Analysis ()

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

Streetwise Reports October 30, 2019
View More Opinion ››

Bullboard Posts ()

added more of this one

using dollar cost averaging for it,and it looks like an upswing is starting today,so glta.
coolfooldumbguy - December 17, 2019

it's a buy today for me

it looks like a comeback is starting,so glta.
coolfooldumbguy - June 20, 2019

Delisting not a problem yet.....

http://www.4-traders.com/INTERPACE-DIAGNOSTICS-GRO-32645693/news/INTERPACE-DIAGNOSTICS-GROUP-INC-Notice-of-Delisting-or-Failure-to...
NipNapTappy - June 24, 2018

Kinda of a new blitz on IDXG

This may go up if for no other reason than the media blitz from analysts. https://www.tipranks.com/stocks/idxg/price-target
NipNapTappy - June 24, 2018

SEC filings look decent...

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12758821&RcvdDate=5/15/2018&CoName=INTERPACE%20DIAGNOSTICS%20GROUP%2C...
NipNapTappy - June 24, 2018

A google search confirms activity is afoot...

https://sportsperspectives.com/2018/06/24/interpace-diagnostics-group-idxg-given-coverage-optimism-rating-of-0-34.html
NipNapTappy - June 24, 2018
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd., an exploration stage company, acquires and explores mineral properties. It explores for gold ...
View More »

Podcasts